Protocol Specific
Protocol Specific
批准号:
8250423
负责人:
HOWARD H. BAILEY
金额:
$11.7万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2013-03-31
关键词:
ClinicalClinical ResearchClinical Research ProtocolsClinical Trials NetworkComprehensive Cancer CenterDataDatabasesDevelopmentFundingGrantLeadMethodsMonitorNursing ResearchPeer ReviewPerformancePhasePilot ProjectsProtocols documentationRecording of previous eventsReportingResearchResearch PersonnelResearch PriorityResearch SupportStagingTranslational ResearchWisconsinbasedata managementflexibilityinnovationmembernoveloncologyprogramsresearch studytranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The UWCCC proposes to have available for its members Protocol Specific Research support for pilot
clinical/translational research studies that would benefit from timely funding. The UWCCC has a long history
of funding pilot studies that have led to more timely clinical research and NCI funding. The UWCCC has
funded 15 (8 of these ongoing or recently initiated) early phase pilot clinical studies over the last grant period
with an accrual of 173 subjects. Efficient accrual to UWCCC-supported studies is enhanced by the
UWCCC-supported statewide clinical trials network (Wisconsin Oncology Network). This method of support
allows investigators with emerging ideas or promising initial pilot data to apply for the support of a research
nurse and data manager to conduct high priority, innovative, feasibility and early stage institutional clinical
research protocols. Proposals will be requested twice yearly and will undergo peer-review (under the
direction of Associate Directors H. Bailey and P. Sondel) with selection based on scientific merit, need for
Protocol Specific Research funding, potential to lead to NCI funding, and UWCCC research priorities. Once
selected, protocols receive research nurse/data management support from this mechanism and all the
necessary developmental and regulatory support via the Oncore database for UWCCC-required monitoring
and reporting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stress keratin 17 and CD4/8 ratio as prognostic markers in HIV-related anogenital squamous cell precancers and cancers (Biospecimens/Biocohort)
-
批准号:10620051
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2022
-
负责人:HOWARD H. BAILEY
-
依托单位:
Defining Tumor Microenvironment and Response to Immune Checkpoint Blockade in HIV-related Anogenital Squamous Cell Carcinomas (Immuno/microenvironment)
-
批准号:10620043
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2022
-
负责人:HOWARD H. BAILEY
-
依托单位:
Creating An Efficient Clinical Trial Build System via The Clinical Trials Rapid Activation Consortium (CTRAC)
-
批准号:10227524
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2020
-
负责人:HOWARD H. BAILEY
-
依托单位:
The MW Cancer Prevention Clinical Trials Network
-
批准号:10252839
-
项目类别:
-
资助金额:$171.64万
-
财政年份:2020
-
负责人:HOWARD H. BAILEY
-
依托单位:
The MW Cancer Prevention Clinical Trials Network
-
批准号:10475114
-
项目类别:
-
资助金额:$165.26万
-
财政年份:2020
-
负责人:HOWARD H. BAILEY
-
依托单位:
The MW Cancer Prevention Clinical Trials Network
-
批准号:10004825
-
项目类别:
-
资助金额:$84.54万
-
财政年份:2020
-
负责人:HOWARD H. BAILEY
-
依托单位:
Clinical Research Central Office
-
批准号:8250421
-
项目类别:
-
资助金额:$32.25万
-
财政年份:2011
-
负责人:HOWARD H. BAILEY
-
依托单位:
Program Leaders
-
批准号:8250405
-
项目类别:
-
资助金额:$23.3万
-
财政年份:2011
-
负责人:HOWARD H. BAILEY
-
依托单位:
Program Leaders
-
批准号:7491879
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2007
-
负责人:HOWARD H. BAILEY
-
依托单位:
Clinical Research Central Office
-
批准号:7491898
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2007
-
负责人:HOWARD H. BAILEY
-
依托单位:
Protocol Specific
-
批准号:7491902
-
项目类别:
-
资助金额:$13.82万
-
财政年份:2007
-
负责人:HOWARD H. BAILEY
-
依托单位:
PHASE 2B DFMO CHEMOPREVENTION OF SKIN CANCERS IN ORGAN TRANSPLANT RECIPIENTS
-
批准号:7607508
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2006
-
负责人:HOWARD H. BAILEY
-
依托单位:
PHASE 2B DFMO CHEMOPREVENTION OF SKIN CANCERS IN ORGAN TRANSPLANT RECIPIENTS
-
批准号:7375510
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2005
-
负责人:HOWARD H. BAILEY
-
依托单位:
CHEMOPREVENTION OF SKIN CANCER: DIFLUOROMETHYLORNITHINE (DFMO) PHASE III TRIAL
-
批准号:7204405
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2005
-
负责人:HOWARD H. BAILEY
-
依托单位:
PHASE 2B DFMO CHEMOPREVENTION OF SKIN CANCERS IN ORGAN TRANSPLANT RECIPIENTS
-
批准号:7204368
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2005
-
负责人:HOWARD H. BAILEY
-
依托单位:
Chemoprevention of Skin Cancer: Difluoromethylornithine (DFMO) Phase III Trial
-
批准号:7043935
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2003
-
负责人:HOWARD H. BAILEY
-
依托单位:
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
-
批准号:8339910
-
项目类别:
-
资助金额:$158.66万
-
财政年份:2003
-
负责人:HOWARD H. BAILEY
-
依托单位:
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
-
批准号:7943303
-
项目类别:
-
资助金额:$166.4万
-
财政年份:2003
-
负责人:HOWARD H. BAILEY
-
依托单位:
DFMO Prevention Study (2b) in Organ Transplant Subjects
-
批准号:6794941
-
项目类别:
-
资助金额:$25.03万
-
财政年份:2002
-
负责人:HOWARD H. BAILEY
-
依托单位:
DFMO Prevention Study (2b) in Organ Transplant Subjects
-
批准号:6542001
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2002
-
负责人:HOWARD H. BAILEY
-
依托单位:
海外基金